These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23028976)

  • 1. Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues.
    Christian ML; Demorest ZL; Starker CG; Osborn MJ; Nyquist MD; Zhang Y; Carlson DF; Bradley P; Bogdanove AJ; Voytas DF
    PLoS One; 2012; 7(9):e45383. PubMed ID: 23028976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.
    Cermak T; Doyle EL; Christian M; Wang L; Zhang Y; Schmidt C; Baller JA; Somia NV; Bogdanove AJ; Voytas DF
    Nucleic Acids Res; 2011 Jul; 39(12):e82. PubMed ID: 21493687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAL effector specificity for base 0 of the DNA target is altered in a complex, effector- and assay-dependent manner by substitutions for the tryptophan in cryptic repeat -1.
    Doyle EL; Hummel AW; Demorest ZL; Starker CG; Voytas DF; Bradley P; Bogdanove AJ
    PLoS One; 2013; 8(12):e82120. PubMed ID: 24312634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction.
    Doyle EL; Booher NJ; Standage DS; Voytas DF; Brendel VP; Vandyk JK; Bogdanove AJ
    Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W117-22. PubMed ID: 22693217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of TALE-DNA interactions suggests polarity effects.
    Meckler JF; Bhakta MS; Kim MS; Ovadia R; Habrian CH; Zykovich A; Yu A; Lockwood SH; Morbitzer R; Elsäesser J; Lahaye T; Segal DJ; Baldwin EP
    Nucleic Acids Res; 2013 Apr; 41(7):4118-28. PubMed ID: 23408851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational predictions provide insights into the biology of TAL effector target sites.
    Grau J; Wolf A; Reschke M; Bonas U; Posch S; Boch J
    PLoS Comput Biol; 2013; 9(3):e1002962. PubMed ID: 23526890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and DNA-binding specificities of Ralstonia TAL-like effectors.
    Li L; Atef A; Piatek A; Ali Z; Piatek M; Aouida M; Sharakuu A; Mahjoub A; Wang G; Khan S; Fedoroff NV; Zhu JK; Mahfouz MM
    Mol Plant; 2013 Jul; 6(4):1318-30. PubMed ID: 23300258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAPTA: a new design tool for improving TALE nuclease activity.
    Lin Y; Fine EJ; Zheng Z; Antico CJ; Voit RA; Porteus MH; Cradick TJ; Bao G
    Nucleic Acids Res; 2014 Apr; 42(6):e47. PubMed ID: 24442582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for sequence-specific recognition of DNA by TAL effectors.
    Deng D; Yan C; Pan X; Mahfouz M; Wang J; Zhu JK; Shi Y; Yan N
    Science; 2012 Feb; 335(6069):720-3. PubMed ID: 22223738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tools for TAL effector design and target prediction.
    Booher NJ; Bogdanove AJ
    Methods; 2014 Sep; 69(2):121-7. PubMed ID: 24981075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities and specificities of homodimeric TALENs in Saccharomyces cerevisiae.
    Aouida M; Piatek MJ; Bangarusamy DK; Mahfouz MM
    Curr Genet; 2014 May; 60(2):61-74. PubMed ID: 24081604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-RVD mutations that enhance the dynamics of the TAL repeat array along the superhelical axis improve TALEN genome editing efficacy.
    Tochio N; Umehara K; Uewaki JI; Flechsig H; Kondo M; Dewa T; Sakuma T; Yamamoto T; Saitoh T; Togashi Y; Tate SI
    Sci Rep; 2016 Nov; 6():37887. PubMed ID: 27883072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted mutagenesis of Arabidopsis thaliana using engineered TAL effector nucleases.
    Christian M; Qi Y; Zhang Y; Voytas DF
    G3 (Bethesda); 2013 Oct; 3(10):1697-705. PubMed ID: 23979944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly of Customized TAL Effectors Through Advanced ULtiMATE System.
    Yang J; Guo S; Yuan P; Wei W
    Methods Mol Biol; 2016; 1338():49-60. PubMed ID: 26443213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain.
    Li T; Huang S; Jiang WZ; Wright D; Spalding MH; Weeks DP; Yang B
    Nucleic Acids Res; 2011 Jan; 39(1):359-72. PubMed ID: 20699274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TAL effector repeat architecture for frameshift binding.
    Richter A; Streubel J; Blücher C; Szurek B; Reschke M; Grau J; Boch J
    Nat Commun; 2014 Mar; 5():3447. PubMed ID: 24614980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity.
    Sakuma T; Ochiai H; Kaneko T; Mashimo T; Tokumasu D; Sakane Y; Suzuki K; Miyamoto T; Sakamoto N; Matsuura S; Yamamoto T
    Sci Rep; 2013 Nov; 3():3379. PubMed ID: 24287550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAL effectors: function, structure, engineering and applications.
    Mak AN; Bradley P; Bogdanove AJ; Stoddard BL
    Curr Opin Struct Biol; 2013 Feb; 23(1):93-9. PubMed ID: 23265998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and efficient assembly of transcription activator-like effector genes by USER cloning.
    Wang S; Li W; Wang S; Hu B
    J Genet Genomics; 2014 Jun; 41(6):339-47. PubMed ID: 24976123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crystal structure of TAL effector PthXo1 bound to its DNA target.
    Mak AN; Bradley P; Cernadas RA; Bogdanove AJ; Stoddard BL
    Science; 2012 Feb; 335(6069):716-9. PubMed ID: 22223736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.